Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioAmber Inc. BIOAQ

BioAmber Inc is an industrial biotechnology company producing renewable chemicals. The company's proprietary technology platform combines industrial biotechnology and chemical catalysis to convert bio-based feedstocks into renewable chemicals that are cost-competitive replacements for petroleum-derived chemicals used in a wide variety of everyday products including plastics, resins, paints... see more

OTCPK:BIOAQ - Post Discussion

BioAmber Inc. > Shorting in the OTC
View:
Post by Mrtkr1 on Feb 12, 2018 4:45am

Shorting in the OTC

There’s been lots of talk about shorting in the OTC so I thought I would give a brief overview.

Shorters in the OTC are required to have $2.50 per share of stock they are going to short. For example, if a shorter wants to short 10,000 shares of Bioa, he/she must have at least $25,000 in their account. Interestingly, the most profit they can make on those 10,000 shares is $880. That’s the max and would occur ONLY if the share price went to zero.

This is why even very large shorters with deep pockets will NOT short stocks under $0.25. In short (no pun intended), we will see almost no new shorters come in as risk is high and payoff is very very low. Existing shorts already have positions but they also have tons to lose and not much to gain. They will try to cover this week. Believe it. Anything else makes zero sense. Since Bioa has been hit with heavy shorters for many months, moving to the OTC has actually been a very positive move from a shorting standpoint. Not sure if managment purposely allowed this to take place but this move is going to make shorting BIOA nearly impossible.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities